These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18462262)

  • 1. Outbreak of exogenous Cushing's syndrome due to unlicensed medications.
    Azizi F; Jahed A; Hedayati M; Lankarani M; Bejestani HS; Esfahanian F; Beyraghi N; Noroozi A; Kobarfard F
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):921-5. PubMed ID: 18462262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case series of abuse of a new opioid combination, Norjizak.
    Siavash M; Janghorbani M; Gheshlaghi F; Adeli SH; Saljoughi M; Moradi F; Majidinezhad M
    J Addict Dis; 2009; 28(2):180-5. PubMed ID: 19340681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous Cushing's syndrome and glucocorticoid withdrawal.
    Hopkins RL; Leinung MC
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):371-84, ix. PubMed ID: 15850848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine free cortisol analysis by automated immunoassay and high-performance liquid chromatography for the investigation of Cushing's syndrome.
    Ching SY; Lim EM; Beilby J; Bhagat C; Rossi E; Walsh JP; Pullan P
    Ann Clin Biochem; 2006 Sep; 43(Pt 5):402-7. PubMed ID: 17022883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of endocrine tests. B: screening for hypercortisolism.
    Holleman F; Endert E; Prummel MF; van Vessem-Timmermans M; Wiersinga WM; Fliers E
    Neth J Med; 2005 Oct; 63(9):348-53. PubMed ID: 16244382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
    Friedman TC
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
    Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
    Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cushing's syndrome from Klack's solution.
    Lankford HV
    Endocr Pract; 2000; 6(6):456-8. PubMed ID: 11155219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of synthetic glucocorticoids by liquid chromatography-tandem mass spectrometry in patients being investigated for Cushing's syndrome.
    Djedovic NK; Rainbow SJ
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):542-9. PubMed ID: 21846739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subclinical Cushing's syndrome:analysis of diagnosis and surgical effect].
    Feng C; Li HZ; Xiao H; Yan WG; Li YQ; Xu WF
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1691-3. PubMed ID: 18476528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical glucocorticoid application causing iatrogenic Cushing's syndrome followed by secondary adrenal insufficiency in infants: two case reports.
    Matejek N; Hoos J; Holterhus PM; Bettendorf M; Choukair D
    J Med Case Rep; 2022 Dec; 16(1):455. PubMed ID: 36476353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factitious, or iatrogenic but unexpected Cushing's syndrome.
    Cristante J; Chabre O
    Ann Endocrinol (Paris); 2023 May; 84(3):370-372. PubMed ID: 36963757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cushing's syndrome from topical glucocorticoids.
    Teelucksingh S; Bahall M; Coomansingh D; Suite M; Bartholomew C
    West Indian Med J; 1993 Jun; 42(2):77-8. PubMed ID: 8367969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's syndrome from the therapeutic use of intramuscular dexamethasone acetate.
    Hughes JM; Hichens M; Booze GW; Thorner MO
    Arch Intern Med; 1986 Sep; 146(9):1848-9. PubMed ID: 3753129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cortisol, cortisone and dexamethasone in human serum using liquid chromatography tandem mass spectrometry and assessment of cortisol: cortisone ratios in patients with impaired kidney function.
    Ray JA; Kushnir MM; Rockwood AL; Meikle AW
    Clin Chim Acta; 2011 Jun; 412(13-14):1221-8. PubMed ID: 21420944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Warning for Cushing's syndrome and withdrawal symptoms in users of the Hong Kong pill].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1978 Oct; 122(42):1633. PubMed ID: 309100
    [No Abstract]   [Full Text] [Related]  

  • 18. Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome.
    Carroll T; Raff H; Findling JW
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):344-50. PubMed ID: 18446140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cushing's syndrome induced by the use of dexamethasone administered nasally in spray form. Report of 3 cases].
    Halpern A; Hayahida CY; Pereira MA; Doi Sde Q; Lottenberg SA; Legrazie MC; Schnaider J; Carneiro CR; Bettarello A
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Feb; 36(1):18-20. PubMed ID: 7280461
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension in Cushing's syndrome.
    Magiakou MA; Smyrnaki P; Chrousos GP
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):467-82. PubMed ID: 16980206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.